Michael Rutledge DeBaun
Michael Rutledge DeBaun
Tina L Cheng
Tina L Cheng
The Pediatric Clinician's Approach for Anxiety, Depression, and Suicide Ideation in Children with Sickle Cell Disease [0.03%]
镰形细胞病儿童焦虑、抑郁和自杀意念的儿科临床处理方法
Robert M Cronin
Robert M Cronin
Mental health conditions in sickle cell disease (SCD) are complex, requiring an integrated, multidisciplinary approach with a medical home model typically headed by the general pediatric clinician. Depression and anxiety are common in SCD a...
Pediatric Clinician's Approach to Benefits and Limitations of Exercise in Children with Sickle Cell Disease and Sickle Cell Trait [0.03%]
镰形红细胞性状和镰形细胞病儿童运动的益处与局限性儿科医师诊治方案
Robert I Liem
Robert I Liem
The pathophysiologic considerations that drive concerns about high-intensity exercise, sports participation, and exertion-related complications are distinct for individuals with sickle cell disease (SCD) versus sickle cell trait (SCT). The ...
The Pediatric Clinician's Approach to Acute or Chronic Neurologic Symptoms in Children with Sickle Cell Disease [0.03%]
sickle细胞病儿童急慢性神经症状的儿科临床处理方法
Djamila L Ghafuri,Lori C Jordan
Djamila L Ghafuri
Neurologic symptoms are common in children with sickle cell disease (SCD) and may cause significant morbidity and mortality. Organized by neurologic chief complaint, this article reviews current knowledge on pathophysiology, clinical presen...
The Pediatric Clinician's Evidence-based Strategies for Anticipatory Management and Treatment of Acute Pain at Home for Children and Adolescents with Sickle Cell Disease [0.03%]
基于证据的儿科临床医生策略：在家为儿童和青少年镰状细胞病患者进行急性疼痛的预见性管理和治疗
Melissa Azul,Amanda M Brandow
Melissa Azul
Acute pain episodes are the most common complications of sickle cell disease (SCD) in children and adolescents, mostly occurring at home and requiring prompt and effective management to prevent progression and comorbidities. Optimal managem...
Hydroxyurea for Children with Sickle Cell Disease: A Practical Guide for Pediatric Clinicians [0.03%]
羟基脲治疗镰状细胞病患儿的实用指南
Francis Coyne,John J Strouse
Francis Coyne
Hydroxyurea is the cornerstone therapy for children with sickle cell disease (SCD). Children with sickle cell anemia (SCA; ∼64% of children with SCD) should be started on hydroxyurea as infants and continue treatment throughout childhood. ...
The Pediatric Clinician's Approach to Referring Children and Adolescents with Sickle Cell Disease for Potentially Curative Therapies [0.03%]
儿科临床医生转诊患有镰状细胞病的儿童和青少年以接受潜在根治性治疗的方法
Tami D John,Lakshmanan Krishnamurti
Tami D John
Pediatric clinicians managing severe features of children with sickle cell disease (SCD) should be aware of the growing landscape of transformative and potentially curative therapies for SCD have been limited until recently, with 2 new US F...
The Pediatric Clinician's Approach to the Diagnosis and Management of Nocturnal Enuresis, Hypertension, and Albuminuria in Children with Sickle Cell Disease [0.03%]
sickle细胞病儿童夜尿症、高血压和蛋白尿的诊断与管理临床方法
Jeffrey Lebensburger,Rima Zahr
Jeffrey Lebensburger
Patients living with sickle cell disease are at an increased risk of developing acute and chronic kidney injury that can progress to the early development of chronic kidney disease in early childhood. In addition, patients living with sickl...
Pediatric Clinicians' Guide to Nutrition and Growth in Children with Sickle Cell Disease [0.03%]
sickle细胞病儿童的营养和生长指南
Lauren J Klein,Claire R Allen,Virginia A Stallings
Lauren J Klein
Children with sickle cell disease (SCD) are at increased risk of growth faltering due to elevated energy demands that are often unmet by dietary intake. Effective strategies to address growth faltering emphasize routine growth monitoring, d...